scholarly journals Studies on the mechanisms of bile acid initiated hepatic inflammation in cholestatic liver injury

2018 ◽  
Vol 4 ◽  
2017 ◽  
Vol 161 (1) ◽  
pp. 34-47 ◽  
Author(s):  
Jibiao Li ◽  
Benjamin L Woolbright ◽  
Wen Zhao ◽  
Yifeng Wang ◽  
David Matye ◽  
...  

2020 ◽  
Vol 158 (6) ◽  
pp. S-1352
Author(s):  
Haiyue He ◽  
Yanliang Hou ◽  
Zichun Li ◽  
Xiaomei Zhang ◽  
Xiaowei Liu

2003 ◽  
Vol 124 (4) ◽  
pp. A697-A698
Author(s):  
Martin Wagner ◽  
Peter Fickert ◽  
Gemot Zollner ◽  
Andrea Fuchsbichler ◽  
Dagmar Silbert ◽  
...  

2021 ◽  
Author(s):  
Yangping Zhu ◽  
Changling Wang ◽  
Jingyi Yu ◽  
Yingying Miao ◽  
Yuanyuan Chai ◽  
...  

Abstract Background: Lithocholic acid (LCA) is one kind of endogenous bile acids which is a typical index in primary biliary cholangitis (PBC). It could cause severe cholestatic liver injury in rodents. Obeticholic acid (OCA) is a major treatment for PBC. However, its effect and mechanism in LCA-induced liver injury was still unclear beside of bile acid regulation. This study aims to evaluate the hepatoprotective effect and mechanism of OCA against LCA-induced cholestatic liver injury. Results: LCA-induced upregulations of ALT, AST, ALP and TBA were reduced and the bile acid profiles in serum, liver and bile were improved significantly by OCA. This bile acid regulating effect of OCA was mainly based on increasing the expression of bile acid efflux transporters bile salt export pump (BSEP), multidrug resistant associated protein 2 (MRP2), MRP3 and multi-drug resistance 3 (MDR3) instead of bile acid synthesis inhibition. Furthermore, it was found that OCA reduced the activation and expression of Caspase 8/3 signaling pathway without the change of p-MLKL and BAX in LCA-induced cholestatic model. And the inhibition of Caspase 8/3 signaling pathway depended on the activation of Farnesoid X receptor (FXR) to inhibit Caspase 8 cleavage to form a active complex.Conclusions: This study found OCA improved LCA-induced cholestatic liver injury via FXR-induced exogenous cell apoptosis, which provided a new evidence for the application of OCA to ameliorate PBC in clinical.


2018 ◽  
Author(s):  
CD Fuchs ◽  
G Paumgartner ◽  
S Wolfrum ◽  
A Wahlström ◽  
M Stahlman ◽  
...  

Phytomedicine ◽  
2019 ◽  
Vol 62 ◽  
pp. 152948 ◽  
Author(s):  
Wen-Kai Li ◽  
Guo-Feng Wang ◽  
Tian-Ming Wang ◽  
Yuan-Yuan Li ◽  
Yi-Fei Li ◽  
...  

2011 ◽  
Vol 63 (3) ◽  
pp. 277-284 ◽  
Author(s):  
Yang-An Wen ◽  
Ding Liu ◽  
Qian-Yun Zhou ◽  
Shi-Feng Huang ◽  
Peng Luo ◽  
...  

Author(s):  
Jie Li ◽  
Xiaoyun Zhu ◽  
Meihui Zhang ◽  
Yanqiu Zhang ◽  
Shengtao Ye ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document